We have shown that both isolated gallic acid and its commercial standard inhibit proliferation and induce apoptosis with similar potencies and significantly augment the efficacy of BCR::ABL1 TKIs in CML cell lines. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.